Brazil

Brazil

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.42 (2.97 - 3.84) 2019 Modelled IHME
3.51 (3.07 - 3.94) 2018 Modelled IHME
3.56 (3.09 - 3.99) 2017 Modelled IHME
3.57 (3.12 - 3.97) 2016 Modelled IHME
3.58 (3.12 - 3.98) 2015 Modelled IHME
3.62 (3.16 - 4.01) 2014 Modelled IHME
3.72 (3.24 - 4.13) 2013 Modelled IHME
3.84 (3.35 - 4.28) 2012 Modelled IHME
3.97 (3.45 - 4.44) 2011 Modelled IHME
4.08 (3.54 - 4.57) 2010 Modelled IHME
4.17 (3.62 - 4.67) 2009 Modelled IHME
4.26 (3.70 - 4.76) 2008 Modelled IHME
4.34 (3.79 - 4.86) 2007 Modelled IHME
4.43 (3.86 - 4.96) 2006 Modelled IHME
4.51 (3.93 - 5.06) 2005 Modelled IHME
4.6 (4.01 - 5.15) 2004 Modelled IHME
4.69 (4.10 - 5.26) 2003 Modelled IHME
4.77 (4.17 - 5.36) 2002 Modelled IHME
4.85 (4.22 - 5.47) 2001 Modelled IHME
4.91 (4.27 - 5.55) 2000 Modelled IHME
4.96 (4.31 - 5.60) 1999 Modelled IHME
5.01 (4.35 - 5.65) 1998 Modelled IHME
5.05 (4.38 - 5.69) 1997 Modelled IHME
5.07 (4.40 - 5.72) 1996 Modelled IHME
5.08 (4.40 - 5.73) 1995 Modelled IHME
5.09 (4.39 - 5.73) 1994 Modelled IHME
5.09 (4.39 - 5.73) 1993 Modelled IHME
5.08 (4.39 - 5.72) 1992 Modelled IHME
5.08 (4.39 - 5.73) 1991 Modelled IHME
5.07 (4.38 - 5.74) 1990 Modelled IHME
7.9 (7 - 8.70) 1999 Survey/reported Silveira TR et al, 1999
0.54 (0.43 - 0.69) 2015 Modelled WHO
0.4 (0.20 - 0.60) 2016 Modelled Razavi-Shearer et al, 2018
0.65 (0.65 - 0.66) 2013 Modelled Schweitzer et al, 2015
0.52 2017 Modelled OPI: Hepatitis B Elimination in Brazil: Revisiting the Current Strategy
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.12 (0.10 - 0.16) 2019 Modelled IHME
0.13 (0.10 - 0.16) 2018 Modelled IHME
0.13 (0.10 - 0.16) 2017 Modelled IHME
0.13 (0.10 - 0.16) 2016 Modelled IHME
0.12 (0.10 - 0.15) 2015 Modelled IHME
0.12 (0.10 - 0.15) 2014 Modelled IHME
0.13 (0.10 - 0.16) 2013 Modelled IHME
0.13 (0.11 - 0.17) 2012 Modelled IHME
0.14 (0.11 - 0.17) 2011 Modelled IHME
0.14 (0.11 - 0.18) 2010 Modelled IHME
0.14 (0.11 - 0.18) 2009 Modelled IHME
0.15 (0.12 - 0.18) 2008 Modelled IHME
0.15 (0.12 - 0.18) 2007 Modelled IHME
0.15 (0.12 - 0.19) 2006 Modelled IHME
0.15 (0.12 - 0.19) 2005 Modelled IHME
0.18 (0.14 - 0.22) 2004 Modelled IHME
0.23 (0.18 - 0.28) 2003 Modelled IHME
0.3 (0.24 - 0.37) 2002 Modelled IHME
0.39 (0.31 - 0.49) 2001 Modelled IHME
0.5 (0.40 - 0.62) 2000 Modelled IHME
0.73 (0.57 - 0.90) 1999 Modelled IHME
1.1 (0.87 - 1.37) 1998 Modelled IHME
1.52 (1.20 - 1.89) 1997 Modelled IHME
1.88 (1.48 - 2.33) 1996 Modelled IHME
2.06 (1.63 - 2.57) 1995 Modelled IHME
2.12 (1.68 - 2.63) 1994 Modelled IHME
2.17 (1.73 - 2.69) 1993 Modelled IHME
2.21 (1.76 - 2.74) 1992 Modelled IHME
2.23 (1.78 - 2.77) 1991 Modelled IHME
2.24 (1.79 - 2.79) 1990 Modelled IHME
0.07 (0.05 - 0.11) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
7,542,260 (6,525,940 - 8,542,390) 1990 Modelled IHME
7,685,680 (6,638,200 - 8,666,600) 1991 Modelled IHME
7,823,470 (6,751,510 - 8,803,610) 1992 Modelled IHME
7,956,160 (6,868,270 - 8,961,310) 1993 Modelled IHME
8,085,250 (6,976,940 - 9,110,970) 1994 Modelled IHME
8,212,800 (7,099,330 - 9,261,150) 1995 Modelled IHME
8,323,540 (7,220,500 - 9,379,150) 1996 Modelled IHME
8,405,900 (7,300,480 - 9,477,690) 1997 Modelled IHME
8,466,750 (7,355,880 - 9,551,650) 1998 Modelled IHME
8,513,080 (7,401,300 - 9,614,000) 1999 Modelled IHME
8,552,640 (7,441,710 - 9,662,090) 2000 Modelled IHME
8,570,860 (7,467,650 - 9,672,800) 2001 Modelled IHME
8,554,820 (7,465,350 - 9,615,550) 2002 Modelled IHME
8,515,290 (7,440,770 - 9,548,920) 2003 Modelled IHME
8,463,850 (7,374,120 - 9,490,060) 2004 Modelled IHME
8,413,090 (7,336,290 - 9,439,060) 2005 Modelled IHME
8,363,800 (7,295,360 - 9,371,020) 2006 Modelled IHME
8,307,390 (7,251,100 - 9,296,900) 2007 Modelled IHME
8,242,770 (7,173,020 - 9,225,390) 2008 Modelled IHME
8,168,640 (7,086,720 - 9,154,570) 2009 Modelled IHME
8,083,640 (7,011,920 - 9,064,050) 2010 Modelled IHME
7,956,620 (6,922,880 - 8,910,720) 2011 Modelled IHME
7,786,630 (6,785,660 - 8,678,550) 2012 Modelled IHME
7,618,800 (6,647,730 - 8,460,660) 2013 Modelled IHME
7,500,330 (6,552,920 - 8,311,680) 2014 Modelled IHME
7,481,030 (6,536,180 - 8,322,960) 2015 Modelled IHME
7,538,600 (6,588,580 - 8,388,080) 2016 Modelled IHME
7,591,620 (6,575,900 - 8,506,510) 2017 Modelled IHME
7,549,980 (6,594,890 - 8,462,030) 2018 Modelled IHME
7,404,410 (6,445,280 - 8,314,650) 2019 Modelled IHME
760,000 (415,000 - 1,249,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
6,064 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.52 (2.24 - 2.83) 2019 Modelled IHME
2.47 (2.22 - 2.78) 2018 Modelled IHME
2.44 (2.19 - 2.72) 2017 Modelled IHME
2.49 (2.22 - 2.78) 2016 Modelled IHME
2.46 (2.20 - 2.76) 2015 Modelled IHME
2.49 (2.24 - 2.78) 2014 Modelled IHME
2.53 (2.26 - 2.83) 2013 Modelled IHME
2.57 (2.31 - 2.87) 2012 Modelled IHME
2.63 (2.36 - 2.93) 2011 Modelled IHME
2.68 (2.41 - 3) 2010 Modelled IHME
2.85 (2.57 - 3.18) 2009 Modelled IHME
3.16 (2.85 - 3.53) 2008 Modelled IHME
3.5 (3.15 - 3.89) 2007 Modelled IHME
3.76 (3.38 - 4.18) 2006 Modelled IHME
3.87 (3.51 - 4.31) 2005 Modelled IHME
3.95 (3.57 - 4.39) 2004 Modelled IHME
3.94 (3.56 - 4.37) 2003 Modelled IHME
3.94 (3.55 - 4.37) 2002 Modelled IHME
3.94 (3.56 - 4.39) 2001 Modelled IHME
3.93 (3.55 - 4.35) 2000 Modelled IHME
3.92 (3.55 - 4.35) 1999 Modelled IHME
3.9 (3.53 - 4.32) 1998 Modelled IHME
3.88 (3.52 - 4.30) 1997 Modelled IHME
3.91 (3.52 - 4.33) 1996 Modelled IHME
3.91 (3.52 - 4.33) 1995 Modelled IHME
3.91 (3.54 - 4.35) 1994 Modelled IHME
3.92 (3.54 - 4.33) 1993 Modelled IHME
3.83 (3.47 - 4.25) 1992 Modelled IHME
3.83 (3.46 - 4.25) 1991 Modelled IHME
3.9 (3.53 - 4.32) 1990 Modelled IHME
0.2 2019 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
5,450 (4,858 - 6,140) 2019 Modelled IHME
5,316 (4,769 - 5,967) 2018 Modelled IHME
5,200 (4,659 - 5,803) 2017 Modelled IHME
5,253 (4,682 - 5,867) 2016 Modelled IHME
5,156 (4,600 - 5,765) 2015 Modelled IHME
5,147 (4,631 - 5,751) 2014 Modelled IHME
5,184 (4,640 - 5,800) 2013 Modelled IHME
5,207 (4,680 - 5,816) 2012 Modelled IHME
5,285 (4,731 - 5,887) 2011 Modelled IHME
5,311 (4,771 - 5,948) 2010 Modelled IHME
5,581 (5,034 - 6,233) 2009 Modelled IHME
6,129 (5,521 - 6,829) 2008 Modelled IHME
6,690 (6,021 - 7,446) 2007 Modelled IHME
7,108 (6,387 - 7,896) 2006 Modelled IHME
7,216 (6,546 - 8,035) 2005 Modelled IHME
7,273 (6,581 - 8,076) 2004 Modelled IHME
7,159 (6,474 - 7,936) 2003 Modelled IHME
7,057 (6,354 - 7,837) 2002 Modelled IHME
6,958 (6,301 - 7,765) 2001 Modelled IHME
6,841 (6,185 - 7,578) 2000 Modelled IHME
6,734 (6,094 - 7,470) 1999 Modelled IHME
6,598 (5,971 - 7,312) 1998 Modelled IHME
6,464 (5,857 - 7,162) 1997 Modelled IHME
6,410 (5,777 - 7,104) 1996 Modelled IHME
6,311 (5,692 - 6,999) 1995 Modelled IHME
6,224 (5,627 - 6,923) 1994 Modelled IHME
6,130 (5,545 - 6,768) 1993 Modelled IHME
5,894 (5,336 - 6,542) 1992 Modelled IHME
5,800 (5,235 - 6,436) 1991 Modelled IHME
5,801 (5,253 - 6,424) 1990 Modelled IHME
14,251 2016 Modelled WHO
368 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
17 (15 - 20) 2019 Modelled IHME
17 (15 - 20) 2018 Modelled IHME
17 (15 - 20) 2017 Modelled IHME
17 (15 - 20) 2016 Modelled IHME
17 (15 - 20) 2015 Modelled IHME
17 (15 - 20) 2014 Modelled IHME
17 (15 - 20) 2013 Modelled IHME
18 (15 - 21) 2012 Modelled IHME
18 (15 - 21) 2011 Modelled IHME
18 (15 - 21) 2010 Modelled IHME
18 (16 - 21) 2009 Modelled IHME
19 (16 - 22) 2008 Modelled IHME
20 (17 - 23) 2007 Modelled IHME
20 (18 - 24) 2006 Modelled IHME
21 (18 - 24) 2005 Modelled IHME
21 (18 - 24) 2004 Modelled IHME
21 (18 - 24) 2003 Modelled IHME
21 (18 - 24) 2002 Modelled IHME
21 (18 - 24) 2001 Modelled IHME
21 (18 - 24) 2000 Modelled IHME
21 (18 - 24) 1999 Modelled IHME
21 (18 - 24) 1998 Modelled IHME
21 (18 - 24) 1997 Modelled IHME
21 (18 - 24) 1996 Modelled IHME
21 (18 - 24) 1995 Modelled IHME
21 (18 - 24) 1994 Modelled IHME
21 (18 - 24) 1993 Modelled IHME
21 (18 - 25) 1992 Modelled IHME
22 (19 - 25) 1991 Modelled IHME
22 (19 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
78 2019 Survey/reported WHO/UNICEF
80 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
82 2016 Survey/reported WHO/UNICEF
91 2015 Survey/reported WHO/UNICEF
88 2014 Survey/reported WHO/UNICEF
89 2013 Survey/reported WHO/UNICEF
90 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
92 2009 Survey/reported WHO/UNICEF
93 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
91 2003 Survey/reported WHO/UNICEF
93 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
63 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
80 2019 Survey/reported WHO/UNICEF
77 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Routine official reports to monitor mortality
Adopted
System for monitoring testing and treatment
Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Adopted
No patient co-pays for HBsAg testing
Adopted
Recommendations for HBV testing of pregnant women
Adopted
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Routine official reports to monitor mortality
Adopted
System for monitoring testing and treatment
Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Registration of generic HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
HCV testing policy
Risk-based
HCV testing recommendations for key population (i.e. PWID)
Adopted
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Partially Adopted
National policy for harm reduction for persons who inject drugs
Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Public budget line for testing and treatment
Adopted

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.5 (2.02 - 3.10) 2019 Modelled IHME
2.45 (1.98 - 3.05) 2018 Modelled IHME
2.44 (1.96 - 3.04) 2017 Modelled IHME
2.51 (2.03 - 3.12) 2016 Modelled IHME
2.58 (2.08 - 3.20) 2015 Modelled IHME
2.57 (2.07 - 3.19) 2014 Modelled IHME
2.55 (2.06 - 3.17) 2013 Modelled IHME
2.53 (2.04 - 3.14) 2012 Modelled IHME
2.5 (2.02 - 3.11) 2011 Modelled IHME
2.48 (2 - 3.09) 2010 Modelled IHME
2.46 (1.98 - 3.06) 2009 Modelled IHME
2.44 (1.96 - 3.04) 2008 Modelled IHME
2.42 (1.94 - 3.01) 2007 Modelled IHME
2.39 (1.92 - 2.98) 2006 Modelled IHME
2.36 (1.89 - 2.95) 2005 Modelled IHME
2.29 (1.84 - 2.86) 2004 Modelled IHME
2.19 (1.75 - 2.73) 2003 Modelled IHME
2.07 (1.66 - 2.58) 2002 Modelled IHME
1.98 (1.59 - 2.47) 2001 Modelled IHME
1.95 (1.56 - 2.42) 2000 Modelled IHME
1.96 (1.57 - 2.44) 1999 Modelled IHME
2.01 (1.60 - 2.50) 1998 Modelled IHME
2.06 (1.64 - 2.57) 1997 Modelled IHME
2.1 (1.68 - 2.63) 1996 Modelled IHME
2.12 (1.69 - 2.66) 1995 Modelled IHME
2.13 (1.69 - 2.66) 1994 Modelled IHME
2.13 (1.69 - 2.67) 1993 Modelled IHME
2.13 (1.69 - 2.67) 1992 Modelled IHME
2.13 (1.69 - 2.67) 1991 Modelled IHME
2.13 (1.69 - 2.67) 1990 Modelled IHME
0.9 (0.60 - 0.90) 2015 Modelled Blach et al, 2017
1.3 (0.10 - 1.30) 2014 Survey/reported Gower et al, 2014
0.53 2017 Modelled OPI: Hepatitis B Elimination in Brazil: Revisiting the Current Strategy
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.22 (0.16 - 0.24) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.38 (1.12 - 1.64) 2013 Survey/reported Pereira LMMB et al, 2014
1.38 2019 Modelled Jin et al. 2017
1.6 (1.10 - 1.60) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
7.3 (1.50 - 19.90) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
39.6 (24.90 - 56.40) 2019 Modelled Granados-Garcia V et al, 2019
63.9 (60.50 - 67.30) 2001 Survey/reported Caiaffa WT et al, 2006
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
3,166,960 (2,522,170 - 3,978,720) 1990 Modelled IHME
3,221,750 (2,563,820 - 4,044,010) 1991 Modelled IHME
3,275,440 (2,605,640 - 4,107,410) 1992 Modelled IHME
3,327,850 (2,647,680 - 4,171,670) 1993 Modelled IHME
3,379,160 (2,689,110 - 4,229,900) 1994 Modelled IHME
3,429,770 (2,730,230 - 4,293,890) 1995 Modelled IHME
3,450,920 (2,748,830 - 4,313,020) 1996 Modelled IHME
3,430,530 (2,736,550 - 4,280,850) 1997 Modelled IHME
3,394,690 (2,712,820 - 4,229,630) 1998 Modelled IHME
3,371,070 (2,697,840 - 4,198,020) 1999 Modelled IHME
3,389,120 (2,714,050 - 4,221,750) 2000 Modelled IHME
3,503,800 (2,803,900 - 4,363,200) 2001 Modelled IHME
3,716,360 (2,968,350 - 4,629,100) 2002 Modelled IHME
3,974,490 (3,177,690 - 4,958,370) 2003 Modelled IHME
4,222,880 (3,380,260 - 5,272,590) 2004 Modelled IHME
4,403,390 (3,528,740 - 5,495,910) 2005 Modelled IHME
4,522,430 (3,626,600 - 5,636,640) 2006 Modelled IHME
4,629,320 (3,710,200 - 5,761,510) 2007 Modelled IHME
4,728,350 (3,799,560 - 5,883,570) 2008 Modelled IHME
4,823,940 (3,886,950 - 6,007,630) 2009 Modelled IHME
4,920,740 (3,963,020 - 6,127,630) 2010 Modelled IHME
5,024,250 (4,046,900 - 6,235,040) 2011 Modelled IHME
5,131,440 (4,130,650 - 6,374,330) 2012 Modelled IHME
5,233,900 (4,213,960 - 6,495,480) 2013 Modelled IHME
5,322,840 (4,292,970 - 6,612,790) 2014 Modelled IHME
5,389,730 (4,357,500 - 6,697,550) 2015 Modelled IHME
5,302,460 (4,282,960 - 6,579,610) 2016 Modelled IHME
5,210,260 (4,186,690 - 6,478,640) 2017 Modelled IHME
5,272,370 (4,248,080 - 6,556,800) 2018 Modelled IHME
5,411,240 (4,369,350 - 6,710,360) 2019 Modelled IHME
1,787,000 (1,293,000 - 1,896,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
128,000 (92,300 - 135,000) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
4.59 (4.11 - 5.11) 2019 Modelled IHME
4.52 (4.09 - 5.03) 2018 Modelled IHME
4.46 (4.05 - 4.95) 2017 Modelled IHME
4.54 (4.11 - 5.05) 2016 Modelled IHME
4.47 (4.05 - 4.97) 2015 Modelled IHME
4.44 (4.03 - 4.92) 2014 Modelled IHME
4.45 (4.03 - 4.92) 2013 Modelled IHME
4.42 (4 - 4.90) 2012 Modelled IHME
4.41 (3.99 - 4.89) 2011 Modelled IHME
4.34 (3.93 - 4.81) 2010 Modelled IHME
4.23 (3.85 - 4.67) 2009 Modelled IHME
4.08 (3.70 - 4.52) 2008 Modelled IHME
3.92 (3.57 - 4.32) 2007 Modelled IHME
3.79 (3.45 - 4.19) 2006 Modelled IHME
3.72 (3.37 - 4.10) 2005 Modelled IHME
3.74 (3.40 - 4.13) 2004 Modelled IHME
3.69 (3.34 - 4.08) 2003 Modelled IHME
3.64 (3.31 - 4.02) 2002 Modelled IHME
3.61 (3.27 - 3.99) 2001 Modelled IHME
3.58 (3.25 - 3.95) 2000 Modelled IHME
3.58 (3.25 - 3.95) 1999 Modelled IHME
3.57 (3.25 - 3.94) 1998 Modelled IHME
3.56 (3.23 - 3.91) 1997 Modelled IHME
3.6 (3.26 - 3.95) 1996 Modelled IHME
3.62 (3.27 - 3.97) 1995 Modelled IHME
3.62 (3.28 - 3.99) 1994 Modelled IHME
3.63 (3.30 - 3.98) 1993 Modelled IHME
3.56 (3.22 - 3.91) 1992 Modelled IHME
3.56 (3.22 - 3.91) 1991 Modelled IHME
3.62 (3.27 - 3.98) 1990 Modelled IHME
0.7 2019 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
9,936 (8,915 - 11,066) 2019 Modelled IHME
9,704 (8,787 - 10,805) 2018 Modelled IHME
9,506 (8,626 - 10,546) 2017 Modelled IHME
9,585 (8,682 - 10,667) 2016 Modelled IHME
9,348 (8,481 - 10,402) 2015 Modelled IHME
9,204 (8,347 - 10,194) 2014 Modelled IHME
9,113 (8,271 - 10,083) 2013 Modelled IHME
8,960 (8,117 - 9,930) 2012 Modelled IHME
8,840 (8,011 - 9,803) 2011 Modelled IHME
8,598 (7,800 - 9,535) 2010 Modelled IHME
8,291 (7,543 - 9,162) 2009 Modelled IHME
7,902 (7,172 - 8,753) 2008 Modelled IHME
7,497 (6,827 - 8,263) 2007 Modelled IHME
7,166 (6,517 - 7,907) 2006 Modelled IHME
6,930 (6,291 - 7,650) 2005 Modelled IHME
6,884 (6,256 - 7,597) 2004 Modelled IHME
6,695 (6,071 - 7,403) 2003 Modelled IHME
6,530 (5,927 - 7,211) 2002 Modelled IHME
6,382 (5,782 - 7,050) 2001 Modelled IHME
6,244 (5,665 - 6,884) 2000 Modelled IHME
6,152 (5,587 - 6,785) 1999 Modelled IHME
6,044 (5,497 - 6,657) 1998 Modelled IHME
5,928 (5,379 - 6,517) 1997 Modelled IHME
5,899 (5,346 - 6,481) 1996 Modelled IHME
5,840 (5,275 - 6,413) 1995 Modelled IHME
5,761 (5,212 - 6,344) 1994 Modelled IHME
5,683 (5,169 - 6,228) 1993 Modelled IHME
5,474 (4,958 - 6,022) 1992 Modelled IHME
5,385 (4,878 - 5,921) 1991 Modelled IHME
5,382 (4,864 - 5,924) 1990 Modelled IHME
7,767 2016 Modelled WHO
1,405 2020 Survey/reported Ministério da Saúde, Brasil: Boletim Epidemiologico de Hepatites Virais - 2021
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
41 (37 - 45) 2019 Modelled IHME
41 (37 - 45) 2018 Modelled IHME
41 (37 - 45) 2017 Modelled IHME
41 (37 - 45) 2016 Modelled IHME
41 (37 - 45) 2015 Modelled IHME
40 (36 - 44) 2014 Modelled IHME
40 (36 - 44) 2013 Modelled IHME
40 (36 - 44) 2012 Modelled IHME
40 (36 - 44) 2011 Modelled IHME
40 (36 - 44) 2010 Modelled IHME
40 (36 - 44) 2009 Modelled IHME
39 (35 - 43) 2008 Modelled IHME
39 (35 - 42) 2007 Modelled IHME
38 (34 - 42) 2006 Modelled IHME
38 (34 - 42) 2005 Modelled IHME
38 (34 - 41) 2004 Modelled IHME
38 (34 - 41) 2003 Modelled IHME
37 (34 - 41) 2002 Modelled IHME
37 (34 - 41) 2001 Modelled IHME
37 (33 - 41) 2000 Modelled IHME
37 (34 - 41) 1999 Modelled IHME
37 (34 - 41) 1998 Modelled IHME
37 (34 - 41) 1997 Modelled IHME
37 (34 - 41) 1996 Modelled IHME
38 (34 - 42) 1995 Modelled IHME
38 (34 - 42) 1994 Modelled IHME
38 (34 - 42) 1993 Modelled IHME
38 (34 - 42) 1992 Modelled IHME
38 (34 - 41) 1991 Modelled IHME
37 (34 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Cumulative number of persons treated for HCV

National
Download
Value Year Type Source
7,459 2015 Survey/reported WHO, 2021
41,226 2016 Survey/reported WHO, 2021
78,666 2018 Survey/reported WHO, 2021
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016

Price of HCV cure (Average price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
2,535.60 2019 Survey/reported WHO, 2021

Price of HCV cure (Cheapest price in public sector for 3 months of DAAs)

National
Download
Value (US $) Year Type Source
705 2019 Survey/reported WHO, 2021
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Routine official reports to monitor mortality
Adopted
System for monitoring testing and treatment
Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Adopted
No patient co-pays for HBsAg testing
Adopted
Recommendations for HBV testing of pregnant women
Adopted
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
Routine official reports to monitor mortality
Adopted
System for monitoring testing and treatment
Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Registration of generic HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
HCV testing policy
Risk-based
HCV testing recommendations for key population (i.e. PWID)
Adopted
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Partially Adopted
National policy for harm reduction for persons who inject drugs
Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
OST in at least one prison
Decriminalization of possession of syringes and paraphernalia
Not Adopted
Public budget line for testing and treatment
Adopted

Overview

HBV elimination goal
HCV elimination goal
Year of goal
2030

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
63 (%)
2020
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources